Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$132K Sell
26,786
-907
-3% -$4.91K ﹤0.01% 5654
2014
Q2
$158K Buy
27,693
+13,979
+102% +$83.2K ﹤0.01% 5404
2014
Q1
$101K Sell
13,714
-1,674
-11% -$12.3K ﹤0.01% 5973
2013
Q4
$110K Buy
15,388
+10,388
+208% +$77.1K ﹤0.01% 5965
2013
Q3
$39K Sell
5,000
-23,099
-82% -$180K ﹤0.01% 7200
2013
Q2
$183K Buy
+28,099
New +$177K ﹤0.01% 5191

Other funds holding ELX

UBS's ELX Position: Q3 2014 in Review

UBS reduced its EMULEX CORP (ELX) stake by 3.3% in Q3 2014, selling an estimated $4.91K and leaving 26,786 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #5654.

UBS first reported a position in ELX in Q2 2013 and has held it in 6 quarters since. The position peaked at $183K in Q2 2013. 147 funds tracked by Wall St. Rank hold ELX as of Q3 2014.

  • UBS held 26,786 shares of EMULEX CORP worth $132K as of Q3 2014.
  • UBS sold 907 EMULEX CORP shares in Q3 2014, an estimated $4.91K.
  • EMULEX CORP made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5654 holding.
  • UBS first reported a position in EMULEX CORP in Q2 2013 and has held it in 6 quarters since.
  • UBS's EMULEX CORP position peaked at $183K in Q2 2013.
  • 147 funds tracked by Wall St. Rank held EMULEX CORP as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.